Howard Hughes Medical Institute’s Hanesbrands HBI Stock Holding History

Howard Hughes Medical Institute’s Portfolio HBI Stock Details HBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-180,000	Closed	-$4.83M	–	181
2014 Q3	$4.83M	Hold	180,000	–	–	1.08%	22
2014 Q2	$4.43M	Sell	180,000 -180,000	-50%	-$3.71M	0.74%	24
2014 Q1	$6.88M	Hold	360,000	–	–	0.98%	12
2013 Q4	$6.32M	Hold	360,000	–	–	0.95%	22
2013 Q3	$5.61M	Sell	360,000 -40,000	-10%	-$595K	0.86%	28
2013 Q2	$5.14M	Buy	+400,000	New	+$4.94M	1.69%	28

Other funds holding HBI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

AIM

abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return

CCM

Chieftain Capital Management New York $3.03M AUM 3.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Howard Hughes Medical Institute's HBI Position: Q4 2014 in Review

Howard Hughes Medical Institute sold out of Hanesbrands (HBI) in Q4 2014, closing a stake of 180,000 shares — an estimated $4.83M sold.

Howard Hughes Medical Institute first reported a position in HBI in Q2 2013 and held it in 6 quarters. The position peaked at $6.88M in Q1 2014. 501 funds tracked by Wall St. Rank hold HBI as of Q4 2014.

Howard Hughes Medical Institute reported no remaining Hanesbrands position as of Q4 2014 after selling out during the quarter.
Howard Hughes Medical Institute sold 180,000 Hanesbrands shares in Q4 2014, an estimated $4.83M.
Howard Hughes Medical Institute first reported a position in Hanesbrands in Q2 2013 and held it in 6 quarters.
Howard Hughes Medical Institute's Hanesbrands position peaked at $6.88M in Q1 2014.
501 funds tracked by Wall St. Rank held Hanesbrands as of Q4 2014.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2014, filed 11 Feb 2015.